{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:32:49Z","timestamp":1789169569898,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T00:00:00Z","timestamp":1561507200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009888","name":"Regione Toscana","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009888","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Basic to Translational Science"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.jacbts.2019.06.004","type":"journal-article","created":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T13:59:38Z","timestamp":1570629578000},"page":"795-813","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Electrophysiological and Contractile Effects of Disopyramide in Patients With Obstructive Hypertrophic Cardiomyopathy"],"prefix":"10.1016","volume":"4","author":[{"given":"Raffaele","family":"Coppini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Ferrantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e8 Manuel","family":"Pioner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Santini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhinuo J.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Palandri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Scardigli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Sacconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Stef\u00e0no","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Flink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Riedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Saverio","family":"Pavone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Cerbai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrado","family":"Poggesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Mugelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Bueno-Orovio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iacopo","family":"Olivotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark V.","family":"Sherrid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacbts.2019.06.004_bib1","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1161\/01.CIR.66.2.447","article-title":"The cardiac effects of d- and l-disopyramide in normal subjects: a noninvasive study","volume":"66","author":"Pollick","year":"1982","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2019.06.004_bib2","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJM198210143071607","article-title":"Muscular subaortic stenosis: hemodynamic and clinical improvement after disopyramide","volume":"307","author":"Pollick","year":"1982","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacbts.2019.06.004_bib3","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/0002-9149(88)90553-X","article-title":"Oral disopyramide therapy for obstructive hypertrophic cardiomyopathy","volume":"62","author":"Sherrid","year":"1988","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacbts.2019.06.004_bib4","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1016\/j.jacc.2011.08.040","article-title":"Long-term survival in patients with resting obstructive hypertrophic cardiomyopathy comparison of conservative versus invasive treatment","volume":"58","author":"Ball","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2019.06.004_bib5","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.jacc.2005.01.012","article-title":"Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy","volume":"45","author":"Sherrid","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2019.06.004_bib6","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1161\/CIRCHEARTFAILURE.112.000122","article-title":"Treatment of obstructive hypertrophic cardiomyopathy symptoms and gradient resistant to first-line therapy with beta-blockade or verapamil","volume":"6","author":"Sherrid","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacbts.2019.06.004_bib7","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1016\/j.jacc.2011.10.825","article-title":"2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"58","author":"Gersh","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2019.06.004_bib8","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2019.06.004_bib9","doi-asserted-by":"crossref","first-page":"e005152","DOI":"10.1161\/JAHA.116.005152","article-title":"Safety of outpatient initiation of disopyramide for obstructive hypertrophic cardiomyopathy patients","volume":"6","author":"Adler","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacbts.2019.06.004_bib10","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.pcad.2012.04.003","article-title":"A\u00a0primer of disopyramide treatment of obstructive hypertrophic cardiomyopathy","volume":"54","author":"Sherrid","year":"2012","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.jacbts.2019.06.004_bib11","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMra1710575","article-title":"Clinical course and management of hypertrophic cardiomyopathy","volume":"379","author":"Maron","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacbts.2019.06.004_bib12","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1161\/01.RES.37.6.844","article-title":"Electrophysiological actions of disopyramide phosphate on canine ventricular muscle and purkinje fibers","volume":"37","author":"Kus","year":"1975","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2019.06.004_bib13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0014-2999(81)90597-5","article-title":"Effects of disopyramide on transmembrane action potentials in guinea-pig papillary muscles","volume":"69","author":"Kojima","year":"1981","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jacbts.2019.06.004_bib14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0306-3623(89)90070-0","article-title":"Evidence that the Na+-Ca2+ exchange system is related to the antiarrhythmic action of disopyramide","volume":"20","author":"Sakai","year":"1989","journal-title":"Gen Pharmacol"},{"key":"10.1016\/j.jacbts.2019.06.004_bib15","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/CIRCULATIONAHA.112.134932","article-title":"Late sodium current inhibition reverses electromechanical dysfunction in human hypertrophic cardiomyopathy","volume":"127","author":"Coppini","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2019.06.004_bib16","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1111\/bph.14223","article-title":"Late sodium current inhibitors to treat exercise-induced obstruction in hypertrophic cardiomyopathy: an in\u00a0vitro study in human myocardium","volume":"175","author":"Ferrantini","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jacbts.2019.06.004_bib17","first-page":"86","article-title":"Isolation and functional characterization of human ventricular cardiomyocytes from fresh surgical samples","author":"Coppini","year":"2014","journal-title":"J\u00a0Vis Exp"},{"key":"10.1016\/j.jacbts.2019.06.004_bib18","doi-asserted-by":"crossref","first-page":"e003565","DOI":"10.1161\/CIRCHEARTFAILURE.116.003565","article-title":"Ranolazine prevents phenotype development in a mouse model of hypertrophic cardiomyopathy","volume":"10","author":"Coppini","year":"2017","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacbts.2019.06.004_bib19","doi-asserted-by":"crossref","first-page":"e005407","DOI":"10.1161\/JAHA.116.005407","article-title":"Pathogenesis of hypertrophic cardiomyopathy is mutation rather than disease specific: a comparison of the cardiac troponin T E163R and R92Q mouse models","volume":"6","author":"Ferrantini","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacbts.2019.06.004_bib20","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/CIRCRESAHA.108.177493","article-title":"Increased Ca2+ sensitivity of the ryanodine receptor mutant RyR2R4496C underlies catecholaminergic polymorphic ventricular tachycardia","volume":"104","author":"Fernandez-Velasco","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2019.06.004_bib21","doi-asserted-by":"crossref","first-page":"C1073","DOI":"10.1152\/ajpcell.00586.2006","article-title":"SparkMaster: automated calcium spark analysis with ImageJ","volume":"293","author":"Picht","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.jacbts.2019.06.004_bib22","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1093\/cvr\/cvx151","article-title":"Hierarchical statistical techniques are necessary to draw reliable conclusions from analysis of isolated cardiomyocyte studies","volume":"113","author":"Sikkel","year":"2017","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2019.06.004_bib23","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.yjmcc.2015.09.003","article-title":"Mechanisms of pro-arrhythmic abnormalities in ventricular repolarisation and anti-arrhythmic therapies in human hypertrophic cardiomyopathy","volume":"96","author":"Passini","year":"2016","journal-title":"J\u00a0Mol Cell Cardiol"},{"issue":"Suppl 3","key":"10.1016\/j.jacbts.2019.06.004_bib24","doi-asserted-by":"crossref","first-page":"iii102","DOI":"10.1093\/europace\/euy226","article-title":"Electrocardiogram phenotypes in hypertrophic cardiomyopathy caused by distinct mechanisms: apico-basal repolarization gradients vs. Purkinje-myocardial coupling abnormalities","volume":"20","author":"Lyon","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.jacbts.2019.06.004_bib25","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF00613817","article-title":"Plasma concentration of disopyramide given as capsules and controlled release tablets","volume":"24","author":"Arnman","year":"1983","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jacbts.2019.06.004_bib26","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1006\/bbrc.2001.4269","article-title":"Inhibition of HERG potassium channel current by the class 1a antiarrhythmic agent disopyramide","volume":"280","author":"Paul","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jacbts.2019.06.004_bib27","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/BF00558240","article-title":"Effects of\u00a0disopyramide on repolarisation and intraventricular conduction in man","volume":"35","author":"Endresen","year":"1988","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jacbts.2019.06.004_bib28","doi-asserted-by":"crossref","first-page":"e0131179","DOI":"10.1371\/journal.pone.0131179","article-title":"Channel activity of cardiac ryanodine receptors (RyR2) determines potency and efficacy of flecainide and R-propafenone against arrhythmogenic calcium waves in ventricular cardiomyocytes","volume":"10","author":"Savio-Galimberti","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jacbts.2019.06.004_bib29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1161\/01.CIR.97.1.41","article-title":"Mechanism of benefit of negative inotropes in obstructive hypertrophic cardiomyopathy","volume":"97","author":"Sherrid","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2019.06.004_bib30","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.echo.2010.10.006","article-title":"Standing and exercise Doppler echocardiography in obstructive hypertrophic cardiomyopathy: the range of gradients with upright activity","volume":"24","author":"Joshi","year":"2011","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.jacbts.2019.06.004_bib31","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.jacc.2006.10.070","article-title":"Effect of obstruction on longitudinal left ventricular shortening in hypertrophic cardiomyopathy","volume":"49","author":"Barac","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2019.06.004_bib32","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.amjcard.2010.06.059","article-title":"Comparison of acute reduction in left ventricular outflow tract pressure gradient in obstructive hypertrophic cardiomyopathy by disopyramide versus pilsicainide versus cibenzoline","volume":"106","author":"Kajimoto","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacbts.2019.06.004_bib33","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/0002-8703(93)90760-7","article-title":"Acute dose-response effects of intravenous disopyramide in hypertrophic obstructive cardiomyopathy","volume":"125","author":"Kimball","year":"1993","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacbts.2019.06.004_bib34","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1126\/science.aad3456","article-title":"A\u00a0small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice","volume":"351","author":"Green","year":"2016","journal-title":"Science"},{"issue":"Suppl 1","key":"10.1016\/j.jacbts.2019.06.004_bib35","first-page":"33","article-title":"The contribution of Na channel block to the negative inotropic effect of antiarrhythmic drugs","volume":"81","author":"Honerjager","year":"1986","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.jacbts.2019.06.004_bib36","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/BF00511411","article-title":"Negative inotropic effects of tetrodotoxin and seven class 1 antiarrhythmic drugs in relation to sodium channel blockade","volume":"332","author":"Honerjager","year":"1986","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.jacbts.2019.06.004_bib37","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00005344-199603000-00007","article-title":"Possible involvement of altered Na+ -Ca2+ exchange in negative inotropic effects of class I antiarrhythmic drugs on rabbit and rat ventricles","volume":"27","author":"Ito","year":"1996","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.jacbts.2019.06.004_bib38","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.yjmcc.2013.04.011","article-title":"Na(+) transport in the normal and failing heart\u2014remember the balance","volume":"61","author":"Despa","year":"2013","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacbts.2019.06.004_bib39","first-page":"222","article-title":"Regulation of intracellular Na(+) in health and disease: pathophysiological mechanisms and implications for treatment","volume":"2013","author":"Coppini","year":"2013","journal-title":"Glob Cardiol Sci Pract"},{"key":"10.1016\/j.jacbts.2019.06.004_bib40","first-page":"H487","article-title":"Frequency-dependent myocardial depression induced by verapamil in conscious dogs","volume":"253","author":"Applegate","year":"1987","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jacbts.2019.06.004_bib41","first-page":"H80","article-title":"Differential effect of verapamil isomers on sinus node and AV junctional region","volume":"244","author":"Gloor","year":"1983","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jacbts.2019.06.004_bib42","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.yjmcc.2009.10.005","article-title":"Flecainide inhibits arrhythmogenic Ca2+ waves by open state block of ryanodine receptor Ca2+ release channels and reduction of Ca2+ spark mass","volume":"48","author":"Hilliard","year":"2010","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacbts.2019.06.004_bib43","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1476-5381.2012.01995.x","article-title":"JTV519 (K201) reduces sarcoplasmic reticulum Ca(2)(+) leak and improves diastolic function in\u00a0vitro in murine and human non-failing myocardium","volume":"167","author":"Sacherer","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jacbts.2019.06.004_bib44","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.yjmcc.2011.09.021","article-title":"Molecular determinants of hERG potassium channel inhibition by disopyramide","volume":"52","author":"El Harchi","year":"2012","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacbts.2019.06.004_bib45","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/00005344-199302000-00019","article-title":"Action potential prolongation exhibits simple dose-dependence for\u00a0sotalol, but reverse dose-dependence for quinidine and disopyramide: implications for proarrhythmia due to triggered activity","volume":"21","author":"Wyse","year":"1993","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.jacbts.2019.06.004_bib46","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1097\/00005344-199506000-00014","article-title":"Kinetics of frequency-dependent conduction delay by class I antiarrhythmic drugs in human atrium","volume":"25","author":"Sakai","year":"1995","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.jacbts.2019.06.004_bib47","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000377622","article-title":"Spatial QT dispersion predicts nonsustained ventricular tachycardia and correlates with confined systodiastolic dysfunction in hypertrophic cardiomyopathy","volume":"131","author":"Magri","year":"2015","journal-title":"Cardiology"},{"key":"10.1016\/j.jacbts.2019.06.004_bib48","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/clpt.1985.131","article-title":"Kinetics and dynamics of disopyramide and its dealkylated metabolite in healthy subjects","volume":"38","author":"Chiang","year":"1985","journal-title":"Clin Pharmacol Ther"},{"issue":"Suppl 1","key":"10.1016\/j.jacbts.2019.06.004_bib49","first-page":"S79","article-title":"The role of sodium channel current in modulating transmural dispersion of repolarization and arrhythmogenesis","volume":"17","author":"Antzelevitch","year":"2006","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacbts.2019.06.004_bib50","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev.physiol.70.113006.100455","article-title":"Calcium cycling and signaling in cardiac myocytes","volume":"70","author":"Bers","year":"2008","journal-title":"Ann Rev Physiol"},{"key":"10.1016\/j.jacbts.2019.06.004_bib51","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jacc.2005.02.090","article-title":"Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy","volume":"46","author":"Ommen","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2019.06.004_bib52","doi-asserted-by":"crossref","first-page":"e004124","DOI":"10.1161\/CIRCHEARTFAILURE.117.004124","article-title":"Efficacy of ranolazine in patients with symptomatic hypertrophic cardiomyopathy: the RESTYLE-HCM randomized, double-blind, placebo-controlled study","volume":"11","author":"Olivotto","year":"2018","journal-title":"Circ Heart Fail"}],"container-title":["JACC: Basic to Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X19301871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X19301871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:21:24Z","timestamp":1762820484000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452302X19301871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":52,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S2452302X19301871"],"URL":"https:\/\/doi.org\/10.1016\/j.jacbts.2019.06.004","relation":{},"ISSN":["2452-302X"],"issn-type":[{"value":"2452-302X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Electrophysiological and Contractile Effects of Disopyramide in Patients With Obstructive Hypertrophic Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"JACC: Basic to Translational Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacbts.2019.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}